Nancy A. Grygiel Amgen Inc (AMGN) insider trading activity

Nancy A. Grygiel is SVP & CCO of AMGEN INC. Currently has a direct ownership of 7,225 shares of AMGN, which is worth approximately $2.47 Million. The most recent transaction as insider was on Mar 06, 2023, when has been sold 968 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.23K

0.22% 3M change

17.63% 12M change

Total Value Held $2.47 Million

Nancy A. Grygiel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2023	BUY Grant, award, or other acquisition	-	968 Added 6.45%	14,032 Common Stock
Nov 08 2022	SELL Open market or private sale	$159,979 $293.54 p/Share	545 Reduced 4.02%	13,009 Common Stock
Nov 05 2022	SELL Payment of exercise price or tax liability	$64,569 $269.04 p/Share	240 Reduced 1.74%	13,554 Common Stock
Jul 31 2022	SELL Payment of exercise price or tax liability	$304,141 $247.47 p/Share	1,229 Reduced 8.22%	13,728 Common Stock
May 05 2022	SELL Payment of exercise price or tax liability	$12,277 $236.1 p/Share	52 Reduced 0.35%	14,869 Common Stock
May 02 2022	SELL Payment of exercise price or tax liability	$13,162 $230.92 p/Share	57 Reduced 0.38%	14,921 Common Stock
May 02 2022	BUY Grant, award, or other acquisition	-	649 Added 4.15%	14,978 Common Stock

Apr 27 2022	SELL Payment of exercise price or tax liability	$14,992 $249.87 p/Share	60 Reduced 0.42%	14,329 Common Stock
Mar 18 2022	SELL Payment of exercise price or tax liability	$82,551 $235.86 p/Share	350 Reduced 2.37%	14,389 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	1,001 Added 6.4%	14,638 Common Stock
Nov 05 2021	BUY Grant, award, or other acquisition	-	935 Added 6.46%	13,547 Common Stock
May 11 2021	SELL Open market or private sale	$631,275 $252.51 p/Share	2,500 Reduced 16.71%	12,461 Common Stock
May 11 2021	BUY Exercise of conversion of derivative security	$406,500 $162.6 p/Share	2,500 Added 14.32%	14,961 Common Stock
May 03 2021	SELL Payment of exercise price or tax liability	$13,180 $239.64 p/Share	55 Reduced 0.44%	12,461 Common Stock
May 01 2021	SELL Payment of exercise price or tax liability	$14,858 $239.64 p/Share	62 Reduced 0.49%	12,516 Common Stock
Apr 30 2021	BUY Grant, award, or other acquisition	-	584 Added 4.44%	12,578 Common Stock
Apr 27 2021	SELL Payment of exercise price or tax liability	$14,565 $255.52 p/Share	57 Reduced 0.47%	11,994 Common Stock
Mar 19 2021	SELL Payment of exercise price or tax liability	$106,323 $244.42 p/Share	435 Reduced 3.48%	12,051 Common Stock
Mar 02 2021	BUY Grant, award, or other acquisition	-	1,245 Added 9.12%	12,401 Common Stock
Aug 03 2020	SELL Payment of exercise price or tax liability	$70,954 $244.67 p/Share	290 Reduced 2.56%	11,026 Common Stock
Jul 31 2020	BUY Grant, award, or other acquisition	-	8,174 Added 41.94%	11,316 Common Stock

NAG

Nancy A. Grygiel

SVP & CCO

Thousand Oaks, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMGN shares.

Notify only if

Value

Insider Trading

Get notified when an Amgen Inc insider buys or sells AMGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMGEN INC

Track Activities on AMGN

Account